• Staar Surgical Co. reports that its first-quarter revenue gains were bolstered by sales of its Visian ICL, which grew approximately 24 percent during the quarter, exceeding the $10 million level for the first time. The company posted a total revenue increase of 16 percent this quarter to $18 million. Final revenue results for the quarter are expected to be released on May 1.

    The company attributes this quarter's approximately 12 percent revenue increase in the U.S. to its ongoing marketing, social media and promotional activities. 

    "Our year is off to a good start, despite currency exchange and backorder challenges," said Barry G. Caldwell, the company's president and CEO. "Visian ICL revenue grew in 10 of our 11 targeted markets during the quarter, allowing us to achieve a quarterly revenue record for the product line."